XKR6 rs117119573 linked to Simvastatin myopathy
Do you have this variant?
Find out →
Upload your raw genetic data once, we'll show you which variants you carry and what the research says.
Key takeaways
- This variant at XKR6 is linked to Simvastatin-induced myopathy with a reported effect size of 9.07 p=8e-6 in about 2 thousand individuals.
- The association comes from a GWAS catalog entry.
- No other traits are reported for this SNP.
Key takeaways
- This variant at the XKR6 locus is linked to Simvastatin-induced myopathy with a reported effect size of 9.07 p=8e-6 in about 2 thousand individuals.
- The association comes from a GWAS catalog entry.
What the research says This variant at XKR6 is associated with Simvastatin-induced myopathy with a reported effect size of 9.07 p=8e-6 in about 2 thousand individuals [PMID 31220337].
Reported associations
- Simvastatin-induced myopathy: this variant is linked to the condition with a reported effect size of 9.07 p=8e-6 in about 2 thousand individuals [PMID 31220337].
Evidence quality The supplied studies do not report a direct trait association for this variant; the rsid appears via GWAS Catalog entry. No lifestyle considerations on file for this variant.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Drug interactions
-
simvastatin Moderate
Associated with simvastatin-induced myopathy (muscle damage)
If statin needed, discuss alternative options like pravastatin with doctor